Report Detail

Chemical & Material Global Isoflurane Sales Market Report 2021

  • RnM3655838
  • |
  • 16 June, 2021
  • |
  • Global
  • |
  • 130 Pages
  • |
  • QYResearch
  • |
  • Chemical & Material

Isoflurane, sold under the trade name Forane among others, is a general anesthetic。It can be used to start or maintain anesthesia.[1] Often another medication is used to start anesthesia due to airway irritation with isoflurane.It is used by inhalation.Side effects include a decreased ability to breathe (respiratory depression), low blood pressure, and irregular heartbeat. Serious side effects may include malignant hyperthermia and high blood potassium.It should not be used in people with a history of malignant hyperthermia in either themselves or their family members.It is unknown if use during pregnancy is safe for the baby, but use during a cesarean section appears to be safe.Isoflurane is in the halogenated ether family of medication.Isoflurane was approved for medical use in the United States in 1979. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.

Market Analysis and Insights: Global Isoflurane Market
The global Isoflurane market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Isoflurane Scope and Market Size
The global Isoflurane market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Isoflurane market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Human Series
Animal Series

Segment by Application
Hospitals
Other Medical Institutions

The Isoflurane market is analysed and market size information is provided by regions (countries). Segment by Application, the Isoflurane market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Piramal Critical Care(Piramal Group)
Halocarbon
Aesica(Consort Medical Group)
Lunan Pharmaceutical Group
Shandong Keyuan Pharmaceutical Co., Ltd.
Pfizer
Indofine Chemical Company, Inc.
Medicon Lifesciences
Rewine Pharmaceutical


1 Isoflurane Market Overview

  • 1.1 Isoflurane Product Scope
  • 1.2 Isoflurane Segment by Type
    • 1.2.1 Global Isoflurane Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Human Series
    • 1.2.3 Animal Series
  • 1.3 Isoflurane Segment by Application
    • 1.3.1 Global Isoflurane Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hospitals
    • 1.3.3 Other Medical Institutions
  • 1.4 Isoflurane Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Isoflurane Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Isoflurane Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Isoflurane Price Trends (2016-2027)

2 Isoflurane Estimates and Forecasts by Region

  • 2.1 Global Isoflurane Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Isoflurane Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Isoflurane Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Isoflurane Revenue Market Share by Region (2016-2021)
  • 2.3 Global Isoflurane Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Isoflurane Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Isoflurane Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Isoflurane Estimates and Projections (2016-2027)
    • 2.4.2 Europe Isoflurane Estimates and Projections (2016-2027)
    • 2.4.3 China Isoflurane Estimates and Projections (2016-2027)
    • 2.4.4 Japan Isoflurane Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Isoflurane Estimates and Projections (2016-2027)
    • 2.4.6 India Isoflurane Estimates and Projections (2016-2027)

3 Global Isoflurane Competition Landscape by Players

  • 3.1 Global Top Isoflurane Players by Sales (2016-2021)
  • 3.2 Global Top Isoflurane Players by Revenue (2016-2021)
  • 3.3 Global Isoflurane Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Isoflurane as of 2020)
  • 3.4 Global Isoflurane Average Price by Company (2016-2021)
  • 3.5 Manufacturers Isoflurane Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Isoflurane Market Size by Type

  • 4.1 Global Isoflurane Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Isoflurane Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Isoflurane Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Isoflurane Price by Type (2016-2021)
  • 4.2 Global Isoflurane Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Isoflurane Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Isoflurane Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Isoflurane Price Forecast by Type (2022-2027)

5 Global Isoflurane Market Size by Application

  • 5.1 Global Isoflurane Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Isoflurane Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Isoflurane Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Isoflurane Price by Application (2016-2021)
  • 5.2 Global Isoflurane Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Isoflurane Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Isoflurane Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Isoflurane Price Forecast by Application (2022-2027)

6 North America Isoflurane Market Facts & Figures

  • 6.1 North America Isoflurane Sales by Company
    • 6.1.1 North America Isoflurane Sales by Company (2016-2021)
    • 6.1.2 North America Isoflurane Revenue by Company (2016-2021)
  • 6.2 North America Isoflurane Sales Breakdown by Type
    • 6.2.1 North America Isoflurane Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Isoflurane Sales Breakdown by Type (2022-2027)
  • 6.3 North America Isoflurane Sales Breakdown by Application
    • 6.3.1 North America Isoflurane Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Isoflurane Sales Breakdown by Application (2022-2027)

7 Europe Isoflurane Market Facts & Figures

  • 7.1 Europe Isoflurane Sales by Company
    • 7.1.1 Europe Isoflurane Sales by Company (2016-2021)
    • 7.1.2 Europe Isoflurane Revenue by Company (2016-2021)
  • 7.2 Europe Isoflurane Sales Breakdown by Type
    • 7.2.1 Europe Isoflurane Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Isoflurane Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Isoflurane Sales Breakdown by Application
    • 7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China Isoflurane Market Facts & Figures

  • 8.1 China Isoflurane Sales by Company
    • 8.1.1 China Isoflurane Sales by Company (2016-2021)
    • 8.1.2 China Isoflurane Revenue by Company (2016-2021)
  • 8.2 China Isoflurane Sales Breakdown by Type
    • 8.2.1 China Isoflurane Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Isoflurane Sales Breakdown by Type (2022-2027)
  • 8.3 China Isoflurane Sales Breakdown by Application
    • 8.3.1 China 242 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 242 Sales Breakdown by Application (2022-2027)

9 Japan Isoflurane Market Facts & Figures

  • 9.1 Japan Isoflurane Sales by Company
    • 9.1.1 Japan Isoflurane Sales by Company (2016-2021)
    • 9.1.2 Japan Isoflurane Revenue by Company (2016-2021)
  • 9.2 Japan Isoflurane Sales Breakdown by Type
    • 9.2.1 Japan Isoflurane Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Isoflurane Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Isoflurane Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Isoflurane Market Facts & Figures

  • 10.1 Southeast Asia Isoflurane Sales by Company
    • 10.1.1 Southeast Asia Isoflurane Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Isoflurane Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Isoflurane Sales Breakdown by Type
    • 10.2.1 Southeast Asia Isoflurane Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Isoflurane Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Isoflurane Sales Breakdown by Application
    • 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Isoflurane Market Facts & Figures

  • 11.1 India Isoflurane Sales by Company
    • 11.1.1 India Isoflurane Sales by Company (2016-2021)
    • 11.1.2 India Isoflurane Revenue by Company (2016-2021)
  • 11.2 India Isoflurane Sales Breakdown by Type
    • 11.2.1 India Isoflurane Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Isoflurane Sales Breakdown by Type (2022-2027)
  • 11.3 India Isoflurane Sales Breakdown by Application
    • 11.3.1 India Isoflurane Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Isoflurane Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Isoflurane Business

  • 12.1 Piramal Critical Care(Piramal Group)
    • 12.1.1 Piramal Critical Care(Piramal Group) Corporation Information
    • 12.1.2 Piramal Critical Care(Piramal Group) Business Overview
    • 12.1.3 Piramal Critical Care(Piramal Group) Isoflurane Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Piramal Critical Care(Piramal Group) Isoflurane Products Offered
    • 12.1.5 Piramal Critical Care(Piramal Group) Recent Development
  • 12.2 Halocarbon
    • 12.2.1 Halocarbon Corporation Information
    • 12.2.2 Halocarbon Business Overview
    • 12.2.3 Halocarbon Isoflurane Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Halocarbon Isoflurane Products Offered
    • 12.2.5 Halocarbon Recent Development
  • 12.3 Aesica(Consort Medical Group)
    • 12.3.1 Aesica(Consort Medical Group) Corporation Information
    • 12.3.2 Aesica(Consort Medical Group) Business Overview
    • 12.3.3 Aesica(Consort Medical Group) Isoflurane Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Aesica(Consort Medical Group) Isoflurane Products Offered
    • 12.3.5 Aesica(Consort Medical Group) Recent Development
  • 12.4 Lunan Pharmaceutical Group
    • 12.4.1 Lunan Pharmaceutical Group Corporation Information
    • 12.4.2 Lunan Pharmaceutical Group Business Overview
    • 12.4.3 Lunan Pharmaceutical Group Isoflurane Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Lunan Pharmaceutical Group Isoflurane Products Offered
    • 12.4.5 Lunan Pharmaceutical Group Recent Development
  • 12.5 Shandong Keyuan Pharmaceutical Co., Ltd.
    • 12.5.1 Shandong Keyuan Pharmaceutical Co., Ltd. Corporation Information
    • 12.5.2 Shandong Keyuan Pharmaceutical Co., Ltd. Business Overview
    • 12.5.3 Shandong Keyuan Pharmaceutical Co., Ltd. Isoflurane Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Shandong Keyuan Pharmaceutical Co., Ltd. Isoflurane Products Offered
    • 12.5.5 Shandong Keyuan Pharmaceutical Co., Ltd. Recent Development
  • 12.6 Pfizer
    • 12.6.1 Pfizer Corporation Information
    • 12.6.2 Pfizer Business Overview
    • 12.6.3 Pfizer Isoflurane Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Pfizer Isoflurane Products Offered
    • 12.6.5 Pfizer Recent Development
  • 12.7 Indofine Chemical Company, Inc.
    • 12.7.1 Indofine Chemical Company, Inc. Corporation Information
    • 12.7.2 Indofine Chemical Company, Inc. Business Overview
    • 12.7.3 Indofine Chemical Company, Inc. Isoflurane Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Indofine Chemical Company, Inc. Isoflurane Products Offered
    • 12.7.5 Indofine Chemical Company, Inc. Recent Development
  • 12.8 Medicon Lifesciences
    • 12.8.1 Medicon Lifesciences Corporation Information
    • 12.8.2 Medicon Lifesciences Business Overview
    • 12.8.3 Medicon Lifesciences Isoflurane Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Medicon Lifesciences Isoflurane Products Offered
    • 12.8.5 Medicon Lifesciences Recent Development
  • 12.9 Rewine Pharmaceutical
    • 12.9.1 Rewine Pharmaceutical Corporation Information
    • 12.9.2 Rewine Pharmaceutical Business Overview
    • 12.9.3 Rewine Pharmaceutical Isoflurane Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Rewine Pharmaceutical Isoflurane Products Offered
    • 12.9.5 Rewine Pharmaceutical Recent Development

13 Isoflurane Manufacturing Cost Analysis

  • 13.1 Isoflurane Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Isoflurane
  • 13.4 Isoflurane Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Isoflurane Distributors List
  • 14.3 Isoflurane Customers

15 Market Dynamics

  • 15.1 Isoflurane Market Trends
  • 15.2 Isoflurane Drivers
  • 15.3 Isoflurane Market Challenges
  • 15.4 Isoflurane Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    Summary:
    Get latest Market Research Reports on Isoflurane . Industry analysis & Market Report on Isoflurane is a syndicated market report, published as Global Isoflurane Sales Market Report 2021. It is complete Research Study and Industry Analysis of Isoflurane market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,000.00
    $6,000.00
    $8,000.00
    3,156.00
    4,734.00
    6,312.00
    3,680.00
    5,520.00
    7,360.00
    620,680.00
    931,020.00
    1,241,360.00
    334,000.00
    501,000.00
    668,000.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report